Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update
Findings of the Comparative Effectiveness Review: Endoscopic Treatments (2 of 2)
Evidence was insufficient to evaluate endoscopic procedures for GERD other than EndoCinch or to compare endoscopic treatments to medication or surgery. Evidence of low strength indicates that lesser degrees of esophagitis were associated with a reduction in the need for PPIs after endoscopic treatment. Evidence of low strength also indicates that sex did not appear to influence outcomes. Evidence of low strength indicates that the following adverse effects were associated with endoscopic treatments: chest or abdominal pain, bleeding, dysphagia, and bloating.
GERD = gastroesophageal reflux disease
PPI = proton pump inhibitor
- Ip S, Chung M, Moorthy D, et al. Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update. Comparative Effectiveness Review No. 29 (Prepared by the Tufts Evidence-based Practice Center under Contract No. HHSA 290-2007-10055-I ). Rockville, MD: Agency for Healthcare Research and Quality; September 2011. AHRQ Publication No. 11-EHC049-EF. Available at www.effectivehealthcare.ahrq.gov/gerdupdate.cfm.
Your slide tray is being processed.